Global Medical REIT Inc.
Simbols: GMRE
NYSE
9.03
USDTirgus cena šodien
30.7150
P/E koeficients
0.5877
PEG koeficients
592.14M
MRK Cap
- 0.09%
DIV ienesīgums
Global Medical REIT Inc. (GMRE) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 7.4 | 4 | 7.2 | |||||||||||||
balance-sheet.row.short-term-investments | 0 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.net-receivables | 0 | 33.7 | 8.2 | 6.2 | |||||||||||||
balance-sheet.row.inventory | 0 | -25.1 | -34.7 | -1.2 | |||||||||||||
balance-sheet.row.other-current-assets | 0 | -41.1 | 18.3 | -50.3 | |||||||||||||
balance-sheet.row.total-current-assets | 0 | 14.4 | 30.5 | 24.9 | |||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 7.6 | 3.5 | 3.8 | |||||||||||||
balance-sheet.row.goodwill | 0 | 5.9 | 5.9 | 5.9 | |||||||||||||
balance-sheet.row.intangible-assets | 0 | 66 | 148.1 | 127.9 | |||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 71.9 | 154 | 133.8 | |||||||||||||
balance-sheet.row.long-term-investments | 0 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.tax-assets | 0 | 1140.3 | -34.7 | -1.2 | |||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 8.5 | 1205.3 | 1100.9 | |||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1253.3 | 1362.7 | 1238.5 | |||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-assets | 0 | 1267.7 | 1393.3 | 1263.5 | |||||||||||||
balance-sheet.row.account-payables | 0 | 12.8 | 13.8 | 10.3 | |||||||||||||
balance-sheet.row.short-term-debt | 0 | 0.4 | 636.4 | 514.6 | |||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 610.8 | 57.7 | 57.2 | |||||||||||||
Deferred Revenue Non Current | 0 | 5.1 | 4.4 | 3.2 | |||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||
balance-sheet.row.other-current-liab | 0 | 601.1 | 11.4 | 15.7 | |||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 42.5 | 78.1 | 85.3 | |||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 13 | 10.5 | 8.1 | |||||||||||||
balance-sheet.row.total-liab | 0 | 661.9 | 744.2 | 625.9 | |||||||||||||
balance-sheet.row.preferred-stock | 0 | 75 | 75 | 75 | |||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | |||||||||||||
balance-sheet.row.retained-earnings | 0 | -239 | -198.7 | -157 | |||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 25.1 | 34.7 | -6.6 | |||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 722.4 | 722 | 711.4 | |||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 583.6 | 633 | 622.8 | |||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1267.7 | 1393.3 | 1263.5 | |||||||||||||
balance-sheet.row.minority-interest | 0 | 22.2 | 16.1 | 14.8 | |||||||||||||
balance-sheet.row.total-equity | 0 | 605.8 | 649.1 | 637.6 | |||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||
Total Investments | 0 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.total-debt | 0 | 624.2 | 694.1 | 571.7 | |||||||||||||
balance-sheet.row.net-debt | 0 | 616.8 | 690.1 | 564.5 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 20.6 | 20 | 18.3 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 58.1 | 57.7 | 47.3 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | -122.1 | 0 | -0.9 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | 4.2 | 4.7 | 5.8 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | -5.7 | -1.7 | -3.8 | ||||||||||||
cash-flows.row.account-receivables | 0 | 0.4 | -3 | -0.7 | ||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0.2 | ||||||||||||
cash-flows.row.account-payables | 0 | -2 | 4.1 | 1.9 | ||||||||||||
cash-flows.row.other-working-capital | 0 | -4.1 | -2.8 | -5.3 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | 113.3 | -4.1 | 2.2 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -10 | -156.2 | -201.7 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 2 | 2.8 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -2 | -2.8 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 86.1 | 11.1 | 4.4 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | -1.3 | 7.8 | 2.6 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 74.8 | -137.3 | -194.7 | ||||||||||||
cash-flows.row.debt-repayment | 0 | -86.1 | -16.7 | -232.2 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 9.9 | 205.5 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 221.6 | ||||||||||||
cash-flows.row.dividends-paid | 0 | -64.8 | -64.2 | -58.3 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 133.4 | -8.9 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -150.9 | 62.4 | 127.7 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -77.5 | 0 | 0 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | -14.9 | 1.7 | 2 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 7.4 | 14.5 | 12.8 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 22.3 | 12.8 | 10.8 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | 68.4 | 76.5 | 69 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | -10 | -156.2 | -201.7 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | 58.4 | -79.7 | -132.7 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 156.7 | 137.3 | 115.9 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 86.2 | 25.2 | 15.5 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 70.4 | 112.1 | 100.4 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | -16.9 | 56.7 | 46.9 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 16.9 | 73.3 | 63.3 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 103.1 | 98.5 | 78.8 | ||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 46.5 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -31.8 | -18.8 | -18.8 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -16.9 | 56.7 | 46.9 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -31.8 | -18.8 | -18.8 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 46.5 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 58.1 | 57.7 | 46.9 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | 53.5 | 38.8 | 37.1 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | 21.7 | 20 | 18.3 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1.1 | 25.2 | 20.4 | ||||||||||||
income-statement-row.row.net-income | 0 | 20.6 | -5.2 | -2.1 |
Biežāk uzdotie jautājumi
Kas ir Global Medical REIT Inc. (GMRE) kopējie aktīvi?
Global Medical REIT Inc. (GMRE) kopējie aktīvi ir 1267700000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.759.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 0.891.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.134.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.345.
Kāda ir Global Medical REIT Inc. (GMRE) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 20612000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 624193000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 16897000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.